Urology · Houston, TX
NPI
1053388785
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
7777 Southwest Fwy, # 1032
Houston, TX, 77074
Phone (713) 351-0644
Groups this clinician bills Medicare through
Medicare paid, 2024
$363K
26,102 services
Medicare patients, 2024
914
Average age 76
Drug cost, 2024
$1.9M
5,718 prescriptions
Company payments, 2025
$8,001
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kevin G Nickell was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 1,081 times for 693 patients. In total Kevin G Nickell billed 26,102 services in 112 codes, and Medicare paid $363K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-27.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,081 | 693 | $11.87 | $13K |
| 81003 Clinical Chemistry | Office | 999 | 654 | $2.20 | $2,198 |
| 99214 Office E&M - Established | Office | 924 | 619 | $87.12 | $80K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 483 | 91 | $48.51 | $23K |
| 36415 Venipuncture Blood Collection | Office | 472 | 338 | $8.40 | $3,966 |
| 99213 Office E&M - Established | Office | 417 | 277 | $64.41 | $27K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 236 | 31 | $136.91 | $32K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 131 | 59 | $37.90 | $4,965 |
| 51798 Ultrasound - Nonspecific | Office | 102 | 86 | $7.47 | $762 |
| 99204 Office E&M - New | Office | 78 | 78 | $119.60 | $9,329 |
| 99203 Office E&M - New | Office | 70 | 70 | $72.27 | $5,059 |
| 99231 Hospital E&M - Subsequent | Facility | 69 | 29 | $38.49 | $2,656 |
| 96402 Chemotherapy Administration | Office | 68 | 37 | $21.90 | $1,489 |
| 99232 Hospital E&M - Subsequent | Facility | 60 | 28 | $62.13 | $3,728 |
| 96372 Injection Administration | Office | 48 | 16 | $10.25 | $492 |
By year: 2022 $314K for 20,751 services; 2023 $337K for 24,052 services; 2024 $363K for 26,102 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 999 | 654 | $2.20 | $2,198 |
| 36415 Venipuncture Blood Collection | 472 | 338 | $8.40 | $3,966 |
Medicare prescription drug claims, 2024
In 2024, the drug Kevin G Nickell prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,697 prescriptions and refills. In total Kevin G Nickell wrote 5,718 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,697 | 4,710 | 546 | $26K |
| Finasteride Generic | 1,214 | 3,419 | 382 | $18K |
| Solifenacin Succinate Generic | 274 | 691 | 94 | $14K |
| Cephalexin Generic | 204 | 334 | 119 | $1,507 |
| Cefdinir Generic | 197 | 197 | 146 | $2,957 |
| Ciprofloxacin Hcl Generic | 186 | 191 | 132 | $863 |
| Gemtesa Vibegron | 180 | 302 | 49 | $142K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 145 | 408 | 46 | $3,389 |
| Levofloxacin Generic | 109 | 109 | 73 | $783 |
| Testosterone Generic | 87 | 129 | 31 | $13K |
| Myrbetriq Mirabegron | 85 | 144 | 26 | $63K |
| Testosterone Cypionate Generic | 75 | 146 | 20 | $4,591 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 71 | 73 | 50 | $1,150 |
| Silodosin Generic | 68 | 177 | 17 | $7,402 |
| Allopurinol Generic | 67 | 197 | 22 | $779 |
Brand drugs: 434 claims; generic drugs: 5,284 claims; opioid claims: 72.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kevin G Nickell $8,001 ($8,001 in general payments such as food, travel and fees) from 25 companies. The largest payer was HMU Consumables, LLC with $5,143.
| Company | Payments | Amount |
|---|---|---|
| HMU Consumables, LLC | 2 | $5,143 |
| Boston Scientific Corporation BSX | 4 | $420 |
| Janssen Biotech, Inc. JNJ | 5 | $286 |
| Pfizer Inc. PFE | 9 | $283 |
| Dendreon Pharmaceuticals LLC | 8 | $261 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 6 | $260 |
| Sumitomo Pharma America, Inc. 4506.T | 9 | $213 |
| Astellas Pharma US Inc 4503.T | 7 | $174 |
| Progenics Pharmaceuticals, Inc. | 4 | $166 |
| Tolmar, Inc. | 3 | $125 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.